Company / Revenue
Xenetic Biosciences, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$2.5M
FY2025
5-year range
$436.9K / $2.5M
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has fluctuated over the past 10 years, ranging from $0 in FY2019 to $8M in FY2018.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +171.1%.
Improved from $2M to $3M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +29.1%
- 5-Year CAGR
- +171.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +171.1%, indicating consistent growth.
- In FY2025, revenue decreased 1.6% year-over-year.
- Peak revenue was recorded in FY2018.
- Lowest revenue in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 0.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.5M | -1.6% |
| FY2024 | $2.5M | +48.8% |
| FY2023 | $1.7M | +47.1% |
| FY2022 | $1.2M | +165.6% |
| FY2021 | $436.9K | +2460.3% |
| FY2020 | $17.1K | - |
| FY2019 | $0 | -100.0% |
| FY2018 | $7.6M | +152.8% |
| FY2017 | $3.0M | - |
| FY2016 | $0 | -100.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026